Evaluating the association between all components of the metabolic syndrome and pre-eclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 6, 2009, Pages 501-509

  Srinivas, Sindhu K ^a   Sammel, Mary D ^a   Bastek, Jamie ^a   Ofori, Ella ^a   Andrela, Christina M ^a   Wolfe, Megan L ^a   Reilly, Muredach ^a   Elovitz, Michal A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hypertensions; Lipids; Metabolic syndrome; Obesity; Pre eclampsia

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; LIPID;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; MATERNAL HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PREECLAMPSIA; PRIORITY JOURNAL; SCORING SYSTEM; BLOOD; CASE CONTROL STUDY; PREGNANCY; PREVALENCE; RISK; RISK FACTOR; TERM BIRTH;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPIDS; METABOLIC SYNDROME X; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; RISK FACTORS; TERM BIRTH;

EID: 69149094367     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050902794642     Document Type: Article

References (36)

1. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, Syverson CJ. Pregnancy-related mortality surveillance - United States, 1991-1999. MMWR 2003;52:1-8.
2. CDC, Achievements in Public Health, Healthier Mothers and Babies; 1990-1999.
3. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;323:1213-1217.
4. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1995;171: 410-416.
5. Sibai BM, Caritis S, Hauth J, Lindheimer M, VanDorsten JP, MacPhersonC, KlebanoffM,LandonM,MiodovnikM, Paul R, Meis P, Dombrowski M, Thurnau G, Roberts J, McNellis D. Risks of pre-eclampsia and adverse neonatal outcome among women with pre-gestational diabetes mellitus.National Institute ofChildHealth andHumanDevelopmentNetwork ofMaternal- FetalMedicineUnits. AmJ Obstet Gynecol 2000;182:364-369.
6. Forest JC, Girouard J, Massé J, Moutquin JM, Kharfi A, Ness RB, Roberts JM, Giguère Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005;105:1373-1380.
7. Pouta A, Hartikainen AL, Sovio U, Gissler M, Laitinen J, McCarthyAR, Elliott P, JarvelinM.Manifestations ofmetabolic syndrome after hypertensive pregnancy. Hypertension 2004;43: 825-831.
8. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005;366:1797-1803.
9. Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L, Harlap S. Long-term mortality after pre-eclampsia. Epidemiology 2005;16:206-215.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Panel (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
12. Grundy SM. Inflammation, hypertension, and the metabolic syndrome. JAMA 2003;290:3000-3002.
13. Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006;38:64-80.
14. Ridker PM, Buring JE, Cook JE, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-397.
15. Ridker PM. C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex Heart Inst J 2005;32: 384-386.
16. Mazar R, Srinivas SK, Sammel MD, Andrela CM, Elovitz, MA. Metabolic score as a novel approach to assessing pre-eclampsia risk. Am J Obstet Gynecol 2007;197:411.el-e5.
17. ACOG Committee on Practice Bulletins - Obstetrics. ACOG practice bulletin. Diagnosis and management of pre-eclampsia and ecclampsia. Number 33, January. Obstet Gynecol 2002; 99:159-167.
18. Reilly MP, Wolfe ML, Localio AR, Rader DJ. C-reactive protein and coronary artery calcification: the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003;23:1851-1856.
19. Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004;110:803-809.
20. Reilly MP, Foulkes AS, Wolfe ML, Rader DJ. Higher order lipase gene association with plasma triglycerides. J Lipid Res 2005;46:1914-1922.
21. McLaughlin MT, Abbasi F, Kim HS, Lamendola C, Schaff P, Reaven G. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 2001;50:795-800.
22. Center for Disease control and Prevention. State specific Prevalence of obesity among adults. United States, 2005. MMWR 2005;55:985-988.
23. Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006;113:379-386.
24. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA.Maternal plasma lipid concentrations in early pregnancy and risk of pre-eclampsia. Am J Hypertens 2004;17:574-581.
25. Belo L, Caslake M, Santos-Silva A, Castro EM, Pereira- Leite L, Quintanilha A, Rebelo I. LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis 2004;177: 391-399.
26. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005;294:2751-2757.
27. Roberts JM. Pre-eclampsia: what we know and what we do not know. Semin Perinatol 2000;24:24-28.
28. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in pre-eclampsia, are positively correlated and decrease within 48 hours postpartum. Am J Obstet Gynecol 1996;174:975-982.
29. Amowitz LL, Ridker PM, Rifai N, Koughrey CM, Komaroff AL. High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction. J Womens Health 2004;13:165-175.
30. Baksu B, Baksu A, Davas I, Akyol A, Gulbaba G. Lipoprotein(a) levels in women with pre-eclampsia and in normotensive pregnant women. J Obstet Gynaecol Res 2005; 31:277-282.
31. Kaaja RK, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005;294:2751-2757.
32. Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, Rajakumar A, Daftary A, Shakir AS, Seely EW, et al. Pre-eclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metabol 2004;89:6239-6243.
33. Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, Giles WH, Kittner SJ. Pre-eclampsia and the risk of ischemic stroke among young women: results from the Stroke prevention in young women study. Stroke 2006;37:1055-1059.
34. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325:157-160.
35. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular risk: metabolic syndrome of pregnancy? Atherosclerosis 2004;175:189-202.
36. Ness RB, Hubel CA. Risk for conronary artery disease and morbid pre-eclampsia; A commentary. Ann Epidemiology 2005;15:726-733.